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Stoyan Ivanov4, Gwendalyn J. Randolph 4, Hellmut G. Augustin 2,3 & Nada A. Abumrad 1,5 ✉

4,

Disruption of lymphatic lipid transport is linked to obesity and type 2 diabetes (T2D), but
regulation of lymphatic vessel function and its link to disease remain unclear. Here we show
that intestinal lymphatic endothelial cells (LECs) have an increasing CD36 expression from
lymphatic capillaries (lacteals) to collecting vessels, and that LEC CD36 regulates lymphatic
integrity and optimizes lipid transport. Inducible deletion of CD36 in LECs in adult mice
(Cd36ΔLEC) increases discontinuity of LEC VE-cadherin junctions in lacteals and collecting
vessels. Cd36ΔLEC mice display slower transport of absorbed lipid, more permeable mesenteric lymphatics, accumulation of inﬂamed visceral fat and impaired glucose disposal. CD36
silencing in cultured LECs suppresses cell respiration, reduces VEGF-C-mediated VEGFR2/
AKT phosphorylation and destabilizes VE-cadherin junctions. Thus, LEC CD36 optimizes
lymphatic junctions and integrity of lymphatic lipid transport, and its loss in mice causes
lymph leakage, visceral adiposity and glucose intolerance, phenotypes that increase risk
of T2D.
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ietary lipids are transported to the circulation predominantly as chylomicrons via the intestinal lymphatic
system, which drains into the subclavian vein1. Chylomicrons enter the intestinal lymphatic capillaries, or lacteals,
through the open “button-like” vascular endothelial (VE)-cadherin junctions localized between adjoining lymphatic endothelial cells (LECs)2. The “zippering” of VE-cadherin junctions,
through deletion of neuropilin1 and vascular endothelial
growth factor receptor 1 (VEGFR1), prevents chylomicron
uptake by lacteals and fat absorption protecting against dietinduced obesity and systemic glucose intolerance2. Similar
metabolic protection is achieved by deletion of vascular endothelial growth factor (VEGF)-C3, or of VEGF-C regulated
Notch ligand delta like−4 (DLL4)4, both important for lacteal
maintenance and remodeling5. On the other hand, mice heterozygous for the transcription factor prospero-related
homeobox 1 (Prox1) important for LEC lineage commitment6
show defective, leaky lymphatic vessels and adult-onset
obesity7. Disruption of lymphatic vessel integrity8,9 and
attenuation of VEGF-C induced lymphangiogenesis10 have
been reported as pathophysiological phenotypes in mice models
of obesity and type 2 diabetes (T2D). In humans, lymphatic
dysfunction is associated with obesity, diabetes, and aging,
which increases the risk of cardiovascular disease, lymphedema
and age-related neurological decline11–15, but our knowledge of
the mechanisms underlying lymphatic dysfunction and its link
to disease remains limited.
The fatty acid transporter CD36/FAT is a transmembrane
scavenger receptor widely expressed in tissues16 and cell types
including endothelial cells17,18. CD36 recognizes long-chain fatty
acids (FAs)16,19, lipoproteins20, pathogen-associated lipids21, in
addition to non-lipid ligands22,23. Studies in rodents24,25 and
people26,27 have shown that CD36 facilitates tissue uptake of nonesteriﬁed FAs, and that of FA released from very low-density
lipoproteins (VLDL)28. CD36 deﬁcient (Cd36−/−) mice have
reduced FA uptake by peripheral tissues, and this reduction was
recapitulated in mice with speciﬁc deletion of endothelial cell
Cd36, highlighting its regulatory role in tissue FA uptake18. There
is little information on CD36 expression level or its role in
the lymphatic endothelium. Although human dermal LECs were
reported to express CD36 mRNA29, cutaneous lymphatic vessels
were found to have low CD36 protein content30 and there is no
evidence for CD36 expression in LECs of the small intestine. We
had previously shown that Cd36−/− mice have reduced lipid
secretion into the cannulated mesenteric lymph duct following
duodenal lipid infusion, and at the time attributed this impairment to the defective generation of chylomicrons by enterocytes
devoid of CD3631,32.
In this study, we show that CD36 is highly expressed in
intestinal lymphatics (lacteals and submucosa) and that Cd36−/−
mice have discontinuous VE-cadherin junctions in gut mucosa
(lacteals) and submucosa lymphatic vessels. To understand the
role of CD36 in LEC function, we generated a mouse with inducible Cd36 deletion in LECs (Prox1-CreERT2-tdTomatoCd36−/−,
hereafter referred to as Cd36ΔLEC) and assessed VE-cadherin
morphological status in gut lymphatics, lymph transport, and
metabolic phenotypes. Mechanistic studies with cultured LECs
highlighted the importance of CD36 in the regulation of oxidative
and glycolytic metabolism. Here, we show that inducible LEC
CD36 deletion in adult mice causes leaky lymphatic vessels in the
mesenteric region, accumulation of inﬂamed visceral adipose tissue, and spontaneous late-onset obesity. CD36 silencing in LECs
inhibits fatty acid oxidation (FAO) and increases glycolytic rates.
The switch in metabolic fuel associates with reduced VEGF-C
signaling to VEGFR2/AKT, which impairs LEC migration, tube
formation and monolayer integrity.
2

Results
Cd36−/− mice have shorter lacteals and disrupted LEC VEcadherin junctions. CD36 is abundantly expressed in blood
microvascular vessels18 but its expression in gut lymphatics is
unstudied. Immunohistochemical analysis of lacteals in the jejunum
of C57BL/6 mice (hereafter referred to as wild type, WT) showed
CD36 staining (green ﬂuorescence) colocalizing with the lymphatic
vessel marker endothelial hyaluronan receptor 1 (LYVE−1, red
ﬂuorescence) (Fig. 1a, left panel, individual staining shown in Supplementary Fig. 1). Similarly, CD36 expression and colocalization
with LYVE-1 were observed in collecting lymphatic vessels in the
submucosa (Fig. 1a, right panel and individual staining in Supplementary Fig. 1). Not all LYVE-1+ cells express CD36, which is in
line with gene expression heterogeneity described in LECs within
lymphatic vessels33. Flow-cytometric analysis of LECs (CD45−
CD90.2+ CD31+ cells) (Fig. 1b) isolated from the jejunal mucosa
(lacteals) and submucosa, and from the collecting vessels in the
mesentery of WT mice (Fig. 1c) showed increasing CD36 expression
from lacteals (mean ﬂuorescence intensity, MFI: 2952) to submucosa
(MFI: 4027) to mesenteric collecting vessels (MFI: 9010).
CD36 staining was absent in Cd36−/− gut LECs and following IgG
isotype control antibody staining used at the same concentration of
the CD36 antibody (Fig. 1c).
To examine if lacteal structure is altered by CD36 deletion, we
performed immunostaining of LYVE-1 and alpha-smooth muscle
actin (αSMA) in intestine whole-mounts. Cd36−/− lacteals in
the jejunum were slightly shorter as compared with those of WT
mice (5.2 ± 0.9 × 102 μm vs. 7.5 ± 0.3 × 102 μm; P < 0.01) often not
extending to the tip of villi (Fig. 2a, b). The density of smooth
muscle ﬁbers surrounding the lacteals and the length of villi
appeared similar in the two mice groups (Fig. 2a, b). Gene
expression of Vegfc and Dll4, critical to lacteal proliferation and
maintenance3,4 was similar (Fig. 2c). Lymphatic function is
regulated by the junctions between adjoining LECs, which consist
of assembled multiprotein complexes that include VE-cadherin2,34.
We examined the morphology of LEC VE-cadherin junctions in
WT and Cd36−/− whole-mount intestines. Lacteals in WT mice
presented both open and closed LEC junctions (Fig. 2d) as
reported in previous studies2,4,34,35. In contrast, lacteals from
Cd36−/− mice showed fragmented VE-cadherin staining (Fig. 2d).
Lymphatic vessels in the submucosa of WT mice had continuous
VE-cadherin junctions, and by comparison the junctions in
Cd36−/− mice were more discontinuous and fragmented (Fig. 2d).
We next examined by microscopy lymph transport following an
intragastric load of the ﬂuorescently labeled tracer long-chain fatty
acid BODIPY C167. BODIPY ﬂuorescence rapidly increased in the
circulation of Cd36−/− mice (Supplementary Fig. 1b) recapitulating
the rapid blood appearance of absorbed TGs in Cd36−/− mice31,
and reﬂecting compromised integrity of blood endothelial vessels,
as shown with Tie2-driven CD36 deletion17. Immunohistochemical analysis of whole-mount mesentery showed no differences in
expression of FoxC2, which identiﬁes lymphatic valves and alphasmooth muscle actin, α-SMA between Cd36−/− and WT mice
(Supplementary Fig. 2). These ﬁndings suggested that CD36
deletion disrupts the organization of VE-cadherin at LEC junctions
in lacteals and collecting vessels and that chylomicrons reach the
circulation directly and independently of lymphatic transport in
Cd36−/− mice.
CD36 deletion in LECs leads to obesity and leaky gut lymphatics. To help dissect out the role of CD36 deletion in the regulation of lymphatic endothelial VE-cadherin junctions, we crossed
Cd36ﬂ/ﬂ17,18 mice with Prox1-CreERT2-tdTomato mice36 to generate a mouse with Cd36 deletion in LECs (Cd36ΔLEC). The deletion
was induced by intragastric administration of tamoxifen at 8 weeks
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Fig. 1 Cd36 expression in gut and mesenteric lymphatic vessels. a Representative staining for CD36 (green) and its colocalization with lymphatic vessel
endothelial hyaluronan receptor 1, LYVE-1, (red) in lymphatic capillaries (lacteals) and in collecting vessels within the submucosa in C57BL/6 wild-type
(WT) mice. Nuclei stained with DAPI (blue). Images were acquired using a Zeiss LSM 880 Airyscan Confocal microscope, ×20 and ×40 objective. Scale
bar: 50 μm (top panel) and 10 μm (bottom and panel). b Flow cytometry to identify intestinal and mesenteric lymphatic endothelial cells (LECs) (CD45–
CD90.2+CD31+). c CD36 expression in LECs isolated from gut mucosa (red) and submucosa (blue), and the mesentery (orange) in WT mice. Jejunum
from Cd36−/− mice and IgG isotype control antibody used at the same concentration as CD36 antibody were included to document CD36 antibody
speciﬁcity. Mice (n = 6) used in (a–c) are 12-week old. SSC side scatter, MFI mean ﬂuorescence intensity, CD cluster of differentiation. Data are
representative of three experiments with n representing the number of mice per group.

of age, every other day for two weeks, to activate Cre recombinase,
which also drives tdTomato reporter expression. Tamoxifen was
similarly administered to ﬂox negative, Cre positive littermate mice
referred to as controls. Validation of the Cd36ΔLEC mouse model
and metabolic studies were conducted at one week after the last
tamoxifen treatment (11-week old) and at 10–11 weeks later (~20week old) with mice maintained on a standard chow diet (Supplementary Fig. 3a). Flow cytometry analysis conﬁrmed that
tdTomato+ cells were primarily (~95%) LECs (CD45−CD90.2+
CD31+) and that tamoxifen treatment reduced CD36 expression
in tdTomato+ cells from 63 to 15% (Supplementary Fig. 3b).
Whole-mount staining showed that tdTomato (red) associated
with LYVE-1+ (green) which identiﬁed lacteals (Supplementary
Fig. 3c). CD36 deletion in LECs was further conﬁrmed by qRTPCR in sorted intestinal tdTomato+ LECs from Cd36ΔLEC mice
while Prox1 mRNA was not altered (Supplementary Fig. 3d).
The Cd36ΔLEC males and female mice developed spontaneous
obesity with age (20-week old) while on the standard chow diet;
body weight was higher in Cd36ΔLEC mice as compared with
controls (body weight in female Cd36ΔLEC mice was 29.1 ± 0.4 g
vs 27 ± 0.4 g in controls, P = 0.016, and in male Cd36ΔLEC mice

33.6 ± 0.5 g vs 26.5 ± 0.2 g in controls, P < 0.01) (Fig. 3a). At
20 weeks, body composition assessed by DEXA showed an
increase in fat mass in both female and male Cd36ΔLEC mice as
compared with their respective controls (female: 8.7 ± 0.2 g vs
6.5 ± 0.3 g; male: 12.3 ± 0.5 g vs 6.5 ± 0.1 g; all P < 0.001) with no
difference in lean mass between groups (female P = 0.327; male
P = 0.154) (Fig. 3b). The increase in weight involved more
accumulation of epididymal fat (P = 0.0033) and also of
subcutaneous fat (P < 0.001) (Fig. 3c, d).
Oral glucose tolerance (OGTT) test showed no difference in
glucose disposal rate in 11-week-old Cd36ΔLEC and control mice
(Fig. 3e), whereas glucose disposal was impaired in Cd36ΔLEC
mice at 20 weeks as compared with the matched controls (P <
0.01) (Fig. 3f). The epididymal adipose tissue was examined for
expression of key adipogenic and inﬂammatory markers in 11and 20-week-old Cd36ΔLEC and the respective controls (Fig. 3g).
At 11 weeks, tissues of Cd36ΔLEC and control mice showed no
differences in gene expression of the lipid storage genes
peroxisome proliferator-activated receptor gamma (Pparg)
and lipoprotein lipase (LpL). Expression of pro-inﬂammatory
interleukin-6 (Il6), and of pro-ﬁbrotic tumor growth factor-beta
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Fig. 2 Cd36−/− mice have shorter lacteals and disorganized VE-cadherin junctions. a Representative whole-mount staining for lymphatic vessel
endothelial hyaluronan receptor 1, LYVE-1, and smooth muscle actin-alpha, αSMA, showing lacteals in jejunum of wild-type (WT) and Cd36−/− mice.
Images were acquired using a Zeiss LSM 880 Airyscan Confocal Microscope, ×20 objective. Scale bar: 50 μm. b Lacteal and villus length quantiﬁed using
ImageJ v1.53i software. Cd36−/− mice lacteal length is reduced as compared to WT (P < 0.01) c mRNA expression of vascular endothelial growth factor C,
Vegfc, and of delta-like ligand 4, Dll4, in jejunum of WT and Cd36−/− mice. d Immunohistochemical analysis performed in whole-mount jejunum stained for
vascular endothelial (VE)-cadherin (red) and LYVE-1 (green) showing disorganized VE-cadherin junctions in Cd36−/− lacteal and in collecting lymphatic
vessels as compared with WT mice. Images were acquired using a Zeiss LSM 880 Airyscan Confocal microscope, ×63 objective. Scale bar is 5 μm. Mice
(n = 6, representative of two independent experiments) used in (a–b) are 12-week old. All data are means ± SE with n representing the number of mice per
group. A.U. arbitrary units. Statistical signiﬁcance is determined by two-tailed Student t test. **P < 0.01.

(Tgfb1) was also similar. However, the expression of genes
encoding for pro-inﬂammatory cytokine Tnf, tumor necrosis
factor alpha, and the macrophage marker EGF modulecontaining mucin-like receptor 1 (Emr1) were increased (P <
0.05 and P < 0.05, respectively) as compared with age-matched
control mice (Fig. 3g). At 20 weeks, Cd36ΔLEC mice showed
~3-fold increases in LpL, Pparg, Tnf, and Il6 gene expression and
4

~7-fold increase in Tgfb1 and Emr1 gene expression (all P <
0.001) (Fig. 3g). These data suggested that inﬂammation of
visceral fat precedes the increase in lipid storage genes, the
expansion of the tissue and the onset of glucose intolerance. We
evaluated energy expenditure in 11- and 20-week-old Cd36ΔLEC
mice and their respective controls. The 11-week-old Cd36ΔLEC
mice showed decreased VCO2 (dark and light periods) (Fig. 4a),
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VO2, and energy expenditure (light period) (Fig. 4b, c) (all P <
0.05) and these differences became even more signiﬁcant at
20 week of age (Fig. 4d–f) (all P < 0.01).
The increase in visceral adiposity in Cd36ΔLEC mice suggested
the possibility that lymphatic integrity might be compromised.
Previously, mice lacking one allele of the homeobox gene Prox17,
the transcription factor important for LEC identity6 were shown

Il 6

T g fb 1

E m r1

to accumulate more visceral fat. We investigated the organization
of LEC VE-cadherin junctions in whole-mount intestines by
immunohistochemistry and found more fragmented VE-cadherin
staining in lacteals (Fig. 5a) and submucosa of Cd36ΔLEC mice as
compared with those in control mice (Fig. 5b). This indicated
that deletion of CD36 in LECs is sufﬁcient to disrupt the
morphological status of VE-cadherin at cellular junctions. As
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Fig. 3 Cd36ΔLEC mice develop spontaneous obesity and adipose tissue inﬂammation. a Body weight (g) of female and male 20-week LEC Cd36 deﬁcient
(Cd36ΔLEC) mice is increased as compared with sex-matched control mice (n = 8); female, P = 0.016; male, P < 0.01. b Body composition analysis shows
similar lean mass between age- and sex-matched controls and Cd36ΔLEC mice (female, P = 0.327; male, P = 0.154), whereas fat mass is higher in both
female and male Cd36ΔLEC mice (both P < 0.01) as compared with sex-matched controls (n = 8). c Representative images of visceral (epididymal and
mesenteric) and subcutaneous fat pads from male mice. d Weight (g) of epididymal (Epi) and subcutaneous (Subcut) fat pads is increased (all P < 0.01) in
Cd36ΔLEC mice as compared with controls (n = 5). e, f Levels of plasma glucose and area under the curve (AUC) during an oral glucose tolerance test in 11and 20-week-old mice (n = 5). Glucose disposal is impaired in Cd36ΔLEC mice at 20 weeks as compared with age-matched controls (P < 0.01). g Gene
expression analysis in epididymal adipose tissue in 11- and 20-week-old Cd36ΔLEC and age-matched control mice (n = 5). As compared with age-matched
controls, 11-week-old Cd36ΔLEC mice show increased gene expression of tumor necrosis factor alpha (Tnf, P < 0.01) and of EGF module-containing mucinlike receptor 1 (Emr1, P < 0.05). The 20-week-old Cd36ΔLEC mice show increased gene expression of lipoprotein lipase (LpL, P < 0.001), peroxisome
proliferator-activated receptor gamma (Pparg, P < 0.001), Tnf (P < 0.001) interleukin-6 (Il6, P < 0.001), tumor growth factor-beta (Tgfb1, P < 0.001) and
Emr1 (P < 0.001). A.U. arbitrary units. All data are means ± SE with n representing the number of mice per group. Statistical signiﬁcance is determined by
two-tailed Student t test. *P < 0.05; **P < 0.01, ***P < 0.001.

Fig. 4 Cd36ΔLEC mice have reduced energy balance. Eleven- and 20-week-old Cd36ΔLEC and control mice (n = 4) were housed in metabolic cages for 48 h
to monitor a, d carbon dioxide release rate (VCO2), b, e O2 consumption (VO2), and c, f energy expenditure. Data are means ± SE with n representing the
number of mice per group. Light grey: 11-week-old control mice; light red: 11-week old Cd36ΔLEC mice. Statistical signiﬁcance is determined by two-tailed
Student t test. *P < 0.05; **P < 0.01.

expected, no differences were observed in VE-cadherin junction
morphology for blood vessels surrounding the lacteals between
the two mouse groups (Supplementary Fig. 4a).
Collecting lymphatic vessels have continuous inter-endothelial
VE-cadherin junctions optimal for lymph transport34 and
disruption of vessel integrity can result in lymph leakage, as has
been reported in mice lacking one allele of Prox17. We examined
lymph transport by lymphatic vessels in the mesentery collecting
vessels of Cd36ΔLEC mice by ﬂuorescence microscopy after an
intragastric load of the green ﬂuorescent long-chain fatty acid
tracer BODIPY C167. While BODIPY highlighted lymph ﬂow and
6

integrity of lymphatic transport in control mice (Fig. 5c), BODIPY
leakage from lymphatic vessels in the mesentery was evident in
Cd36ΔLEC mice (Fig. 5c). We next examined how lymph leakage in
Cd36ΔLEC mice impacts lymph transport of absorbed lipid to the
circulation. The Cd36ΔLEC and control mice received an
intragastric bolus of olive oil after injection of Triton WR 1339
to inhibit lipoprotein lipase and rapid clearance of plasma
triglycerides (TGs)31. In control mice, plasma TG levels increased
at 1 h (600 ± 90 mg/dl) following the oral fat bolus, peaked at 3 h
(846 ± 151 mg/dl), decreased at 5 h (452 ± 139 mg/dl) and
returned back to pre-meal levels after 7 h (166 ± 28 mg/dl).
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Fig. 5 Cd36ΔLEC mice have more discontinuity of LEC VE-cadherin junctions and leaky mesenteric lymphatic vessels. Representative images of wholemount VE-cadherin (green) immunohistochemistry in (a) lacteals and (b) submucosa collecting vessels in 20-week-old Cd36ΔLEC and control mice (n = 5).
TdTomato (TdTom, red) identiﬁes PROX1 positive cells. Images were acquired in tiled scans using a Zeiss LSM 880 Airyscan Confocal Microscope, ×40
objective. Scale bar is 5 μm. c Fluorescent long-chain fatty acid tracer BODIPY C16 was administered intragastrically and integrity and transport function of
lymphatic vessels recorded using a stereomicroscope. Scale bars: 500 μm. Right panel shows high-magniﬁcation image of the area outlined by the white
dashed box (Scale bar: 200 μm). Images are representative of two independent experiments with n representing the number of mice per group.

In contrast, as compared with controls, plasma TG levels in
Cd36ΔLEC mice were ~50% lower at 1 h (P < 0.01), maintained a
plateau between 3 h, and remained higher at 5 and 7 h (P < 0.05
and P < 0.001 respectively). (Supplementary Fig. 4b). Thus, lipid
absorption was delayed and prolonged in Cd36ΔLEC mice in line
with the disruption of lymphatic transport. In summary, the data
show that CD36 deletion in LECs of adult mice disrupts lymphatic
VE-cadherin junctions and increases lipid permeability of
mesenteric lymphatic vessels. Lipid transport to the circulation
is delayed which prolongs the postprandial TG phase. The

Cd36ΔLEC mice accumulate visceral adipose tissue that is inﬂamed
and display glucose intolerance.
Disruption of lymphatic vessel integrity8,9 has been reported in
mice models of obesity and T2D. We examined if diet-induced
obesity affects LEC CD36 expression in WT mice fed a high-fat
diet (HFD) for 12 weeks. The HFD did not affect CD36 protein
expression in mucosa LECs (lacteals) as compared to chow diet
condition (P = 0.36), but it increased CD36 expression in LECs
from submucosa and mesenteric lymphatic vessels as compared
to gut LECs from mice fed chow diet (P < 0.01 and P < 0.001
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Fig. 6 High-fat diet feeding induces obesity and adipose tissue inﬂammation in Cd36ΔLEC mice but not in Cd36−/− mice. a Eight-week-old male and
female wild-type (WT) mice (n = 3) were fed either chow diet (CD) or high-fat diet (HFD) for 12 weeks. CD36 expression was measured by ﬂow
cytometric analysis in lymphatic endothelial cells (LECs) (CD45−CD90.2+CD31+) isolated from gut mucosa, submucosa, and mesentery lymphatic
vessels. CD36 expression is increased in LEC isolated from gut submucosa and mesenteryic vessels (P < 0.01 and P < 0.001, respectively). MFI: mean
ﬂuorescence intensity. b Body weight of Cd36−/− and Cd36ΔLEC mice, and respective controls (n = 6), fed HFD for 12 weeks. *Depicts signiﬁcance between
Cd36ΔLEC and Cd36WT mice (4 weeks, P < 0.001; 8 weeks, P < 0.01; 12 weeks, P < 0.001)#, depicts signiﬁcance between WT vs Cd36−/− mice (4 weeks,
P < 0.05; 8 weeks, P < 0.01; 12 weeks, P < 0.05). c Epidydimal fat pad weight (g) is decreased in Cd36−/− mice as compared to WT mice (P < 0.001),
whereas epidydimal fat pad weight is increased in Cd36ΔLEC mice as compared to controls (P < 0.01) fed HFD for 12 weeks. d Cytokine gene expression is
decreased in Cd36−/− epididymal adipose tissue as compared to WT mice (n = 6) fed HFD for 12 weeks. e Cytokine gene expression is increased in
Cd36ΔLEC epididymal adipose tissue as compared to controls (n = 6) fed HFD for 12 weeks. Tumor necrosis factor alpha, Tnf; Interleukin-6, Il6; Interleukin10, Il10; EGF module-containing mucin-like receptor 1, Emr1. A.U. arbitrary units. All data are from two independent experiments and are means ± SE with n
representing the number of mice per group. Statistical signiﬁcance is determined by two-tailed Student t test. * and #P < 0.05; **P < 0.01; ***, P < 0.001;
****P < 0.0001.
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respectively) (Fig. 6a). In addition, Cd36−/−, Cd36ΔLEC mice and
their controls were included in the HFD regimen to compare
effects on body weight, epididymal fat mass, and markers of
inﬂammation. The HFD resulted increases body weight and
epididymal fat mass in Cd36ΔLEC mice as compared to controls
(4 weeks, P < 0.001; 8 weeks, P < 0.01; 12 weeks, P < 0.001), while
germline Cd36−/− mice, did not gain as much body weight, as
compared to WT mice (4 weeks, P < 0.05; 8 weeks, P < 0.01;
12 weeks, P < 0.05) (Fig. 6b, c), as previously reported37. HFD
associated with increased expression of genes encoding for key
proinﬂammatory cytokines in epididymal fat of WT and control
mice and these genes showed further upregulation in epididymal
fat of Cd36ΔLEC mice (P < 0.001 and P < 0.0001). The Cd36−/−
mice accumulated less epididymal fat as compared to WT mice
(P < 0.001) and displayed low adipose tissue inﬂammation
documented by decreased expression of key pro-inﬂammatory
cytokines (all P < 0.001) (Fig. 6d, e). These data show that HFD
increases CD36 expression in collecting lymphatics, which would
optimize vessel transport of the absorbed fat and chronically
could contribute to weight gain.

CD36 siRNAs reduced cell migration (both P < 0.001) as
compared with Ctrl siRNA LECs (Fig. 8a, b). VEGF-C induced
tube formation was decreased only by CD36 siRNA1 (branch points
P < 0.001; tube length P < 0.001) (Fig. 8c). We next examined
whether CD36 silencing impacts the morphology of VE-cadherin
junctions in LECs. VEGF-C treatment of 6-h serum-starved LECs
induced visible smoothening of VE-cadherin into continuous, linear
junctions but this effect was diminished in CD36 siRNA LECs
(Fig. 8d). A similar pattern was observed with VEGF-A treatment
(Fig. 8d). VE-cadherin protein levels were not changed by
CD36 silencing (Fig. 8e). In addition to being regulated by VEGFC, the status of VE-cadherin itself inﬂuences VEGFR2 and AKT
signaling47. We examined if the attenuated actions of VEGF-C in
siRNA CD36 LECs reﬂect impaired VEGF-C signaling. As
compared with Ctrl siRNA LECs, VEGF-C signaling to VEGFR2
and AKT was reduced in CD36 siRNA LECs as phosphorylation of
VEGFR2 at Y1175 and of AKT at S473 (P < 0.05) was suppressed
(Fig. 8f, g). Plasma membrane CD36 level was not changed by
VEGF-C treatment or serum omission suggesting that CD36
cycling48–50 is unaltered (Supplementary Fig. 5).

CD36 regulates LEC oxidative metabolism and function
in vitro. To understand if the compromised lymphatic integrity
observed in Cd36ΔLEC mice can be related to autonomous CD36
regulation of LECs, we examined the impact of CD36 silencing in
human dermal LEC function in vitro. LECs have robust CD36
expression (Fig. 7a) and a 60–80% reduction of CD36 protein
content was achieved using two different CD36 siRNAs (Fig. 7a, b)
(P < 0.0001). CD36 silencing in LECs did not affect expression of
genes encoding the fatty acid transporters FATPs, namely SLC27A1,
SLC27A3, and SLC27A4, as compared with control (Ctrl) siRNA
LECs (Fig. 7c). HDLECs have negligible expression of SLC27A5 and
SLC27A6 as previously reported38. LEC function relies on fatty acid
β-oxidation (FAO)29, a pathway shown to be regulated by CD36 in
several cell types39–43. CD36 silencing lowered by ~50% basal
respiration measured by oxygen consumption rate (OCR) as compared with Ctrl siRNA LECs (P < 0.05) whereas ATP-linked and
maximal OCR did not differ. VEGF-C treatment (16 h) increased
basal, ATP-linked OCR, and maximal OCR (P < 0.01 and P < 0.001)
in Ctrl siRNA LECs. However, the effect of VEGF-C on cell
respiration was largely prevented by CD36 silencing for all three
OCR measurements (all P < 0.01) (Fig. 7d, e). We examined the
effect of CD36 silencing on glucose utilization by assessing extracellular acidiﬁcation rate (ECAR), which measures lactate production. In control siRNA LECs, VEGF-C signiﬁcantly increased
glycolysis and glycolytic rates as compared to untreated cells (both P
< 0.001). In contrast, CD36 siRNA LECs had substantially increased
glycolysis under basal condition (all P < 0.01) that did not respond
to VEGF-C stimulation (Fig. 7f, g). In line with the above data,
CD36 silencing in VEGF-C treated LECs signiﬁcantly reduced gene
expression of key enzymes of FAO, namely carnitine palmitoyltransferase 1, Cpt1a (P < 0.001), long-chain fatty acid-CoA ligase 1,
Acsl1 (P < 0.01) as previously reported44, and very long-chain acylCoA dehydrogenase, Vlcad (P < 0.001), as previously reported45
(Fig. 7h) while it increased gene expression of glycolysis related
genes, glucose transporter 1 (GLUT1) (P < 0.0001), hexokinase 2
(HK2) (P < 0.05) and aldolase A (ALDOA) (P < 0.001) (Fig. 7i). The
same glucose utilization genes were increased by VEGF-C treatment
in Ctrl siRNA LECs (P < 0.01), as previously reported46, but did not
respond to VEGF-C in CD36 siRNA LECs. Expression of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB) was
unaltered by CD36 silencing or VEGF-C treatment (Fig. 7i). In vivo
relevance of these ﬁndings was shown by measuring decreased
mRNA of Cpt1a (P < 0.01), Acsl1 (P < 0.05) and Vlcad (P < 0.01) and
increased mRNA of Glut1 (P < 0.001) in LECs sorted from 20-weekold Cd36ΔLEC mice as compared to those from controls (Fig. 7j).

Discussion
The current study increases our understanding of the regulation of
intestinal lymphatics by documenting the role of the fatty acid
transporter CD36 in the maintenance of lymphatic vessel integrity.
The ﬁndings mechanistically explain our previous observations that
Cd36−/− mice have reduced lipid secretion into the cannulated
mesenteric lymph duct31. We show that CD36 is abundantly
expressed in intestinal LECs, although not all Lyve-1 expressing cells
have CD36, which is in line with the reported heterogeneity of gene
expression and function of LECs33. We describe an increasing CD36
expression gradient from lacteals to lymphatic vessels in submucosa
and mesentery and an effect of high-fat diet to upregulate CD36
level in LECs isolated from collecting lymphatic vessels. Germline
deletion of CD36 (Cd36−/−) in mice reduced length of the lacteals
and impaired organization of VE-cadherin junctions, which
appeared fragmented and reduced in density. The shorter lacteals in
Cd36−/− mice do not reﬂect reduced proliferation as this was likely
sustained by the increase in basal glycolysis observed in CD36
deﬁcient LECs. Glycolytic rates in LECs are much higher than FAO
rates51 and fuel cellular proliferation and migration, while FAO
plays a role in promoting transcription of key lymphangiogenic
genes29. Shorter lacteals were not observed in Cd36ΔLEC mice suggesting that potential differences in gradient of angio- and lymphangiogenic growth factors, important for LEC migration and tube
formation, in addition to the reduced VEGF-C mediated signaling,
might have caused the shorter lacteals in Cd36−/− mice.
The Cd36ΔLEC displayed more discontinuity of VE-cadherin
junctions and lymph leakage from collecting lymphatics following
intragastric administration of a ﬂuorescent lipid tracer. The mice
developed spontaneous visceral and also subcutaneous adiposity,
inﬂammation of the visceral fat and systemic glucose intolerance
(Fig. 9). Together these data suggest that the primary function of
LEC CD36 is to optimize lymphatic vessel integrity and lymph
transport of dietary fat.
The lymphatic dysfunction in Cd36ΔLEC mice reﬂected
autonomous regulation by CD36 in LECs. Depletion of CD36 in
LECs from Cd36ΔLEC reduced the expression of genes encoding
key enzymes of FAO such as CPT1A and ACSL1 while increasing
expression of those related to glucose utilization such as Glut1.
CD36 silencing (CD36siRNA LECs) reduced cell respiration but
signiﬁcantly increased basal glycolytic rate and expression of the
key glucose utilization genes GLUT1 and HEK2. Both FAO and
glycolysis are important for lymphatic maintenance and are
enhanced by VEGF-C to fuel cell migration, and tube sprouting
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during lymphangiogenesis29,52. CD36 silencing reduced VEGF-C
action to upregulate gene expression of GLUT1, HEK2, and
CPT1A and its ability to stimulate cell respiration, glycolysis, cell
migration, and tube formation. The defects in tube formation and
migration appear mediated by VEGF-C signaling through
VEGFR2 and AKT; VEGF-C activation of VEGFR2Y1175 and
AKTS473 was inhibited by CD36 silencing. The VEGFR2 pathway
10

regulates the morphology of VE-cadherin junctions in LECs2,
and AKT activity independently contributes to junction
stabilization53. VEGF-C treatment did not optimize continuity of
VE-cadherin junctions in CD36 depleted LECs as it did in
control LECs.
Consistent with the LEC autonomous effect of CD36 deﬁciency
to increase discontinuity of VE-cadherin junctions shown by the
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Fig. 7 CD36 regulates lymphatic endothelial cell oxidative metabolism. Human dermal lymphatic endothelial cells (LECs) transfected at 40–60%
conﬂuence with either control (Ctrl siRNA) or CD36 Silencer® Pre-designed siRNA (CD36 siRNA1 and 2) are assayed at 95–100% conﬂuence. a, b CD36
knockdown evaluated by western blotting and quantiﬁed (n = 4 per condition) (P < 0.001). A.U. arbitrary units, kDa kilodalton. c Expression of genes
encoding for fatty acid transporters (Slc27a1, Slc27a3, and Slc27a4) in Ctrl and CD36 siRNA LECs (n = 4 per condition). d, e LEC oxygen consumption rate
(OCR) proﬁle and its quantiﬁcation by Seahorse (*P < 0.05; **P < 0.01; ***P < 0.001). f, g Extracellular acidiﬁcation (ECAR) rate and its quantiﬁcation by
Seahorse (**P < 0.01; ***P < 0.001). e, g (quantiﬁcation: each bar represents 6 wells/condition averaged for three time points, n = 18) are representative of
two independent experiments. h–i Expression of genes encoding for key enzymes of fatty acid β-oxidation (FAO) and glycolysis in Ctrl and CD36 siRNA
LECs with/without VEGF-C treatment (16 h). Carnitine palmitoyltransferase 1a, CPT1a; Long-chain fatty acid CoA ligase 1, ACSL1; Very long-chain acyl-CoA
dehydrogenase, VLCAD; Glucose transporter 1, GLUT1; Hexokinase 2, HK2; Aldolase A, ALDOA; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3,
PFKFB. (j) Expression of key FAO genes Cpt1a (P < 0.01), Acsl1 (P < 0.05), Vlcad (P < 0.01), and of Glucose transporter 1, Glut1 (P < 0.001) in LECs sorted
from 20-week-old Cd36ΔLEC and control mice (n = 3). A.U. arbitrary units. Data are means ± SE with n representing the number of mice per group.
Statistical signiﬁcance is determined by two-tailed Student t test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

in vitro data, both Cd36−/− and Cd36ΔLEC mice displayed more
discontinuous VE-cadherin junctions in intestinal whole mounts
as compared with respective controls. Cd36ΔLEC mice maintained
on a HFD accumulated more fat mass and had exacerbated
inﬂammation of epididymal fat while the Cd36−/− mice were
protected. The differences in adiposity between these mice models
likely reﬂect several factors. Cd36ΔLEC mice express CD36 on
blood endothelial cells as well as on adipocytes, while global
CD36 loss in Cd36−/− mice suppresses blood endothelial FA
delivery to tissues and mitigates diet-induced obesity18,37. Lacteal
LEC junctions were highly fragmented in Cd36−/− mice and
when intragastric BODIPY C16 was administered we observed a
rapid increase of ﬂuorescence levels in the circulation. This is in
line with previous ﬁndings in Cd36−/− mice where impaired lipid
secretion into the cannulated mesenteric lymph duct, abnormally
rapid blood appearance of absorbed TG31, and reduced integrity
of blood endothelial vessels17 were observed. Thus, in Cd36−/−
mice chylomicrons likely reach the circulation directly and
independently of lymphatic transport. By comparison, lacteal
junctions in Cd36ΔLEC mice although more discontinuous were
not as fragmented as in Cd36−/− mice, so lymphatic lipid
transport occurred but was defective resulting in lymph leakage
with onset of inﬂammation and obesity.
Our ﬁndings in mice and cultured LECs suggest that a major
functional consequence of LEC CD36 deﬁciency is impairment of
lymphatic vessel barrier integrity. The mesenteric lymph vessels
of Cd36ΔLEC mice leaked the ﬂuorescent long-chain fatty acid
tracer BODIPY C16, and these vessels are closely associated with
abdominal fat depots, which contributes to the expansion of
mesenteric and visceral adipose depots, as previously observed in
mice with Prox1 haploinsufﬁciency7. Fatty acids from the lymph
were shown to promote proliferation and differentiation of preadipocytes and the hypertrophy of adipocytes54. We also measured enhanced gene expression of LpL in visceral adipose tissue
of Cd36ΔLEC mice, which could augment fatty acid availability
from chylomicrons present in the leaked lymph. The accumulated
visceral fat in Cd36ΔLEC mice had several fold increases in gene
expression of proinﬂammatory markers Tnf and Il6, of the proﬁbrotic Tgfb1 and of the macrophage marker Emr1 that associates
with inﬂamed adipose tissue55,56. These proinﬂammatory changes are likely consequent to the leaked lymph diverting to adipose
tissue immune cells that would have normally trafﬁcked to lymph
nodes57. In support of this, we found signiﬁcant upregulation of
Tnf and Emr1 gene expression in the adipose tissue of 11-weekold Cd36ΔLEC mice before upregulation of the lipid storage genes
LpL and Pparg, observed later in 20-week-old Cd36ΔLEC mice.
Thus, inﬂammation in adipose tissue precedes the onset of obesity and glucose intolerance in Cd36ΔLEC mice. Chronic inﬂammation of visceral adipose tissue is linked to the etiology of
systemic insulin resistance58–60, as pro-inﬂammatory mediators,
particularly IL-6, reach the liver through the portal system which

drains blood from the visceral fat depot61. In addition, we
observed a small reduction in energy expenditure in 11-week-old
Cd36ΔLEC mice, as compared with controls, which might have
contributed to the weight increase. We cannot exclude contribution of other organs62–64 to some of the phenotypes
observed in Cd36ΔLEC mice. The decrease in energy expenditure
might be driven by alterations in intestinal homeostasis, namely
inﬂammation and/or changes in the microbiota65.
In summary, our ﬁndings connect integrity and function of
gut/mesenteric lymphatic to expression of CD36, a protein with
regulatory inﬂuence in energy metabolism13. It is interesting to
note the parallel between the function of LEC CD36 which
optimizes transport of absorbed lipid from the intestine to the
circulation for distribution to tissues, and that of blood endothelial cell CD36 which optimizes cellular uptake of FAs from the
circulation to tissue parenchymal cells18. This suggests that CD36
regulation of nutrient bioavailability is not solely deﬁned by its
function in cellular FA uptake.
Deﬁciency of CD36 in LECs highlights a new mechanism for
the etiology of visceral obesity and insulin resistance, two phenotypes linked to the metabolic syndrome, which increases risk of
cardiovascular disease and T2D, pathologies that associate with
CD36 genetic variants66–68. Genetically determined low CD36
mRNA associates with incidence of T2D and its metabolic
complications in genome-wide/RNA sequencing data68 and vascular endothelial dysfunction is observed in individuals carrying
the minor allele of a coding CD36 single nucleotide
polymorphism69. Considering the important function of the
lymphatic system in tissue homeostasis, LEC CD36 might also
contribute to disease association.
Methods
Mice and metabolic studies. Female and male C57BL/6 wild-type (WT) and Cd36null (Cd36−/−) mice24 were used at 12–14 weeks. Sex- and age-matched WT mice
were used as controls of Cd36−/− mice. Male and female mice with Cd36 deletion in
LECs were obtained by crossing Prox1-CreERT2-tdTomato reporter mice36 with
Cd36ﬂ/ﬂ mice17,18 to generate Prox1-CreERT2-tdTomatoCd36ﬂ/ﬂ (referred to as
Cd36ΔLEC). Flox negative, Cre positive littermate mice were used as controls (referred
to as controls). All mice were on a C57BL/6 background and were bred in the same
facility. Cre-mediated deletion was induced in 8-week-old mice by intragastric
administration of tamoxifen (20 mg/ml) in corn oil (Sigma Aldrich) three times/week
for two weeks. Littermate controls received the same tamoxifen protocol. High-fat diet
studies were conducted in 8-week-old male and female WT, Cd36−/−, Cd36ΔLEC and
control mice fed 60% kcal Fat (Research Diet Inc. Cat# D12492) for 12 weeks. All mice
were housed in a 12 h light-dark cycle, and at a temperature of 65–75 °F (18–23 °C)
with 40–60% humidity, in full-barrier facilities.
Whole-body fat and lean mass were assessed with an EchoMRI Whole Body
Composition AnalyzerBody (Echo Medical Systems). For oral glucose tolerance test
(OGTT), intragastric glucose (2 g/kg, Sigma-Aldrich) was given to mice fasted for
6 h and tail blood collected at 0, 15, 30, 60, 120, and 180 min for glucose
measurements. Single-chamber indirect calorimetry system (Columbus
Instruments) was used for dark and light periods for 48 h in the fed state using
chow diet. O2 consumption (VO2), CO2 production (VCO2), and energy
expenditure were measured for 48 h. All animal studies were performed in
accordance with the guidelines provided by the National Institute of Health. All
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Fig. 8 CD36 deletion impairs lymphatic endothelial cell function, VE-cadherin morphology, and VEGFR2/AKT activation. Human dermal lymphatic
endothelial cells (LECs) are transfected with either control (Ctrl siRNA) or CD36 Silencer® Pre-designed siRNA (CD36 siRNA1 and 2). a, b VEGF-C
mediated migration (both siRNAs P < 0.001) (n = 8 per condition). Scale bar: 500 µm. c Tube formation: CD36siRNA1: branch points P = 0.047; tube
length P = 0.04 versus Ctrl siRNA (n = 8–6 per condition). d Fully conﬂuent Ctrl siRNA and CD36 siRNA 1 LECs (n = 3/condition) are serum starved (6 h)
and exposed to VEGF-C (100 ng/ml) or VEGF-A (50 ng/ml) for 20 min. Immunohistochemistry of VE-cadherin depicts junctional morphology in Ctrl and
CD36 siRNA LECs following treatments. e VE-cadherin and CD36 expression in Ctrl and CD36 siRNA LECs. f Western blot analysis and (g) densitometric
quantiﬁcation of CD36 (P < 0.001), VEGFR2, p-VEGFR2Y1175 (P < 0.05), AKT, p-AKTS473 (P < 0.01) expression in Ctrl and CD36 siRNA LECs (n = 3 per
condition) following the addition of VEGF-C (100 ng/ml, 20 min). Actin protein is the loading control. VE-cad, VE-cadherin; kDa, kilodalton. Data are
representative of two independent experiments and are means ± SE. Statistical signiﬁcance is determined by two-tailed Student t test. *P < 0.05; **P < 0.01;
***P < 0.001.
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Fig. 9 CD36 deletion in lymphatic endothelial cells associates with obesity and glucose intolerance. CD36 expression in lymphatic endothelial cells
(LECs) follows an increasing gradient from gut mucosa to submucosa to collecting mesentery vessels. CD36 deletion in LECs in adult mice (Cd36ΔLEC)
increases discontinuity of VE-cadherin junctions and associates with lymph leakage in the mesentery. Inﬂammation of visceral fat, age-associated obesity
and glucose intolerance are observed in 20-week-old Cd36ΔLEC mice. The mechanism likely involves reduced signaling of VEGF-C in LECs, which leads to
disorganization of LEC junctions and impairs cell migration and tube formation. Image created using BioRender.com.
protocols for the animal studies were reviewed and approved by the animal Ethical
Committees at Washington University School of Medicine.
Flow cytometry and LEC sorting. Intestines were separated off the mesentery. The
jejunum was then opened longitudinally and, after removal of Peyer’s patches,
gently scraped off to physically separate the mucosal layer (lacteals) from the
submucosa by using a cell scraper. The submucosa was washed twice with DTT/
EDTA on a shaker at 37 °C, followed by enzymatic digestion using the Miltenyi
Lamina Propria Dissociation kit (Miltenyi Biotech) for 30 min, per manufacturer’s
instructions, whereas gut mucosa and mesentery were directly digested for 30 min.
The three cell suspensions were stained with an antibody cocktail (Supplementary
Table 1). CD36 expression was measured on LECs identiﬁed as CD45−CD90.2+
CD31+ 70. Doublets and dead cells, positive for LIVE/DEAD Fixable Aqua (Life
Technologies), were excluded from analyses. Cells were analyzed using FACS
Fortessa (BD Biosciences) and FlowJo v10 software (Treestar). LECs were sorted
(BD FACSAria II, BD Biosciences) by the tdTomato-positive population in jejunum of control and Cd36ΔLEC mice.
Endothelial cell tube formation and migration assays. Human Dermal LECs,
from PromoCell were cultured in EBM-2MV medium (Lonza). For siRNA treatment, the LECs were grown to 60–80% conﬂuence and transfected with either
control or CD36 Silencer® Pre-designed siRNA, as per the manufacturer ’s
instructions (Ambion). The Boyden chamber migration assay was performed using
serum-starved Ctrl and CD36 siRNA treated LECs (50,000 cells/insert) grown on
transwell inserts (8 µm pore size) coated with 10 µg/ml ﬁbronectin (30 min at

37 °C). Migration was stimulated by adding 100 ng/ml VEGF-C (R&D System) and
25 ng/ml β-FGF to the lower well. LECs migrated for 24 h then supernatants were
aspirated, the inserts washed and ﬁxed with ice-cold methanol and LECs stained
with Hoechst dye. Images of the lower side of inserts were taken and nuclei of
migrated cells/well quantiﬁed using ImageJ v1.53i software (NIH). Tube formation
was assayed in basal medium supplemented with 2% FCS, 100 ng/ml VEGF-C, and
25 ng/ml β-FGF. Ctrl and CD36 siRNA-treated LECs (25,000 cells/well) were
seeded in 48-well plates with wells pre-coated with growth factor-reduced Matrigel
(150 µl solidiﬁed at 37 °C for 30 min). Bright ﬁeld images of capillary-like tubes
were taken after 12 h at 37 °C for quantiﬁcation. Mean tube length and branch
points were quantiﬁed using ImageJ v1.53i software.
Seahorse. Oxygen consumption rate (OCR) and basal extracellular acidiﬁcation
rate (ECAR) values were obtained using the XFp Mito Stress Kit using the Seahorse
XF96 Extracellular Flux Analyzer (Seahorse Biosciences). Brieﬂy, LECs (2.5 × 105
cells/well) were plated in XF96 cell plates 24 h before the assay and treated 16 h
with/without 100 ng/ml VEGF-C (R&D System). Before assay, cells were switched
to bicarbonate free media supplemented with pyruvate (1 mM), glucose (10 mM),
and glutamine (2 mM) and kept 1 h in a non-CO2 incubator at 37 °C. Oligomycin
(3 μM), carbonyl cyanide-p triﬂuoromethoxyphenylhydrazone (FCCP, 2.5 μM) and
antimycin A/rotenone (2 μM) were added to the appropriate injection ports.
Western blotting. Overnight serum-starved LECs were treated with 100 ng/ml
VEGF-C (R&D System) for 20 min at 37 °C, lysed (20 min) in cold buffer (20 mM
Tris-HCL, pH 7.5, 150 mM NaCL, 1% Triton X-100, 60 mM octyl β-D-
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glucopyranoside, 200 μM sodium orthovanadate, 50 mM NaF, 1 mM PMSF, and 1
μg/ml protease inhibitor mix) and the cleared lysates (10,000 × g, 10 min) assayed
for protein (Pierce Biotech). Proteins separated on 4–20% gradient gels were
transferred to polyvinylidene ﬂuoride membranes (Merk Millipore), blocked (LiCOR Biosciences) 1 h at room temperature before adding primary antibodies
(Supplementary Table 1) overnight at 4 °C. Infrared dye–labeled secondary antibodies were added for 1 h at room temperature. Protein signals were detected using
the Li-Cor Odyssey Infrared (Li-COR Biosciences) and quantiﬁed using Image
Studio Lite v5.2 Software.

4.
5.

6.
7.
8.

RNA extraction and qRT-PCR. RNA was extracted using TRIzol (Invitrogen) and
subjected to cDNA reverse transcription. Q-RT-PCR was performed using Power
SYBR Green PCR Master Mix on a 7500 Fast Real-Time PCR System (Applied
Biosystems). Relative mRNA fold changes were calculated using standard δCt.
Primer sequences are listed in (Supplementary Table 2).
Immunohistochemistry and whole-mount imaging. Mice jejunums opened
longitudinally, were ﬁxed (4% formaldehyde) and parafﬁn embedded. Sections
(5 μm) were deparafﬁnized and had antigen retrieval (99 °C, 18 min) in a pressurized chamber (Biocare Medical). Sections were incubated in donkey serum (2%)
and BSA (3%) for 1 h at room temperature, and then overnight (4 °C) with primary
antibodies (Supplementary Table 1) followed by ﬂuorescently labeled (Alexa Fluor)
secondary antibodies (1:250). For whole-mount staining, jejunums were ﬁxed (4%
formaldehyde for 2–4 h) and incubated in buffer with 5% non-immune donkey
serum, 0.1% Triton-X, 1% BSA, and 0.05% NaN3 in PBS (1 h, room temperature)
then with primary antibodies in blocking buffer (2 days, 4 °C), washed with PBST
(0.1% TritonX-100 in PBS, 3 × 45 min) and ﬂuorescent secondary antibodies
(Invitrogen) were added overnight at 4 °C. Following PBST washes, tissues were
post-ﬁxed with 1% formaldehyde (10 min, room temperature) and PBS washed. As
primary antibody control, staining employing each ﬂuorescent secondary Abs was
used. For LEC VE-cadherin staining, cells were cultured in complete media and
used at 100% conﬂuency. After serum starvation for 6 h, LECs were treated with
VEGF-C (100 ng/mL), or VEGF-A (50 ng/mL) (both from R&D System) for
20 min. Cells were then ﬁxed (4% formaldehyde, 10 min, room temperature),
permeabilized (0.1% Triton X-100/PBS, 2 min), and blocked (1% BSA/PBS,
30 min). Anti-VE-cadherin antibody (1 h) and ﬂuorescent secondary antibody
(30 min) were added at room temperature, each followed by 3 × 10 min PBS
washes. Stained tissues and cells were mounted using the ﬂuorescent mounting
medium (DAKO Inc.) and whole-plane z-stack images acquired on a Zeiss LSM
880 Airyscan Confocal Microscope using ×20, ×40 or ×63 objectives. For lacteal
structure, villi and lacteal length were measured with ImageJ v1.53i software (NIH).
Analysis of lymphatic vessel function. To analyze lymph transport by mesenteric
lymphatic vessels, mice received intragastrically 0.1 mg of BODIPY FL C16 (4,4diﬂuoro-5,7-dimethyl-4-bora-3a, 4a-diaza-s-indacene-3-hexadecanoic acid, Molecular
Probes, Inc.) in heavy cream. Mice were sacriﬁced 2 h later and transport of ﬂuorescent lipid visualized by Zeiss Stereo Lumar v.12 ﬂuorescence stereomicroscopy.

9.
10.
11.
12.

13.
14.
15.
16.

17.

18.
19.

20.

21.
22.
23.

Statistical analyses. All data shown are means ± standard error (SE). Statistical
signiﬁcance was evaluated using two-sided Student’s t test with a p value of ≤0.05
indicating signiﬁcant differences. Graphpad Prism software (version 8.4.3) was
used for all statistical analyses and to plot quantitative data.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
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